To provide the information your oncologist is not telling you or doesn't have the time to!
Exploring the Human Side of Cancer Through Art and Stories
Immerse yourself in the human experience of cancer through our “Art of Oncology” category. Here, we delve into the emotional and personal aspects of cancer diagnosis and treatment. Explore stories of courage, resilience, and hope shared by survivors, caregivers, and healthcare professionals. Experience the healing power of art, creativity, and storytelling as we navigate the profound impact of cancer on individuals and their families.
The Development of Targeted Therapy The development of targeted therapies over the past 20 years has significantly changed how we treat cancer. These therapies are designed to focus on specific molecules that help cancer cells grow and survive. By targeting these exact processes, targeted therapies provide a more personalized approach to treatment, often working better …
A Difficult Choice: Hope vs. Quality of Life James is a 62-year-old patient with advanced pancreatic cancer. After enduring multiple rounds of chemotherapy, he finds himself at a crossroads. His oncologist presents him with an option: a new experimental treatment offered through a clinical trial. This treatment carries the potential to extend his life by …
Ethan’s New Reality At 24, Ethan was excited about his future—finishing college, starting his dream job, and maybe even finding love. But everything changed when he was diagnosed with Stage II Hodgkin’s lymphoma. The news hit hard. Ethan felt overwhelmed by fear and uncertainty, worrying about his studies, job, and future plans. His vibrant future …
EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) EGFR (epidermal growth factor receptor) is a protein located on the surface of cells that regulates their growth and division. Mutations in the EGFR gene can lead to uncontrolled cell growth and are commonly found in various cancers, including non-small cell lung cancer (NSCLC). In patients with unresectable stage …
In the ever-evolving landscape of cancer care, the role of the oncology nurse navigator has emerged as a cornerstone of patient support and care coordination. In this post, we’ll explore the origins of oncology navigation, emerging trends, and what the future holds. We will also include some significant changes in billing practices that are on …
Stage III melanoma means the cancer has spread beyond the original tumor to nearby areas but hasn’t reached distant parts of the body. The prognosis for Stage III melanoma varies depending on several factors, including the extent of lymph node involvement, the presence of in-transit or satellite lesions, and the patient’s overall health. Treatment for …
As I step away from my role as a medical oncologist at Orlando Health, I find myself reflecting on the remarkable journey that has spanned the last 13 years. It’s a bittersweet moment, filled with a mix of gratitude, pride, and anticipation for what lies ahead as I finish up my last days by the …
Multiple myeloma (MM) is a type of blood cancer that originates in the plasma cells, which are a type of white blood cell found in the bone marrow. Plasma cells are responsible for producing antibodies that help fight infections. In multiple myeloma, abnormal plasma cells multiply uncontrollably, leading to a range of complications. Key Characteristics …
When it comes to battling a rare and aggressive cancer like synovial sarcoma, the treatment options have often been limited—until now. The FDA’s recent approval of Tecelra (Amafi-Cel), the first gene therapy for adults with metastatic synovial sarcoma, not only provides new hope for patients who’ve exhausted other options but also paves the way for …
Meet Sarah, a resilient woman in her late 40s who has been battling stage IV metastatic melanoma. After enduring the uncertainties of her diagnosis, Sarah achieved a remarkable remission through immunotherapy, a victory that brought her and her loved ones immense relief. However, the journey doesn’t end there. Sarah now faces the ongoing challenge of …